Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.640
-0.170 (-3.53%)
Aug 10, 2026, 11:05 AM EDT - Market open
Lexeo Therapeutics Employees
Lexeo Therapeutics had 59 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
59
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,483,068
Market Cap
364.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 59 | 0 | - |
| Dec 31, 2025 | 59 | -13 | -18.06% |
| Dec 31, 2024 | 72 | 14 | 24.14% |
| Dec 31, 2023 | 58 | 34 | 141.67% |
| Dec 31, 2021 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Lyell Immunopharma | 161 |
| Enanta Pharmaceuticals | 120 |
| Foghorn Therapeutics | 106 |
| C4 Therapeutics | 104 |
| Century Therapeutics | 78 |
| Upstream Bio | 75 |
| Compass Therapeutics | 39 |
LXEO News
- 3 days ago - Lexeo Therapeutics management to meet with Cantor - TheFly
- 5 days ago - Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy - GlobeNewsWire
- 5 weeks ago - Lexeo Therapeutics Transcript: Fireside chat - Transcripts
- 6 weeks ago - Lexeo Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Lexeo Therapeutics price target lowered to $9 from $12 at JPMorgan - TheFly
- 7 weeks ago - Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia - GlobeNewsWire
- 2 months ago - Lexeo Therapeutics Transcript: Investor update - Transcripts
- 2 months ago - Lexeo Therapeutics Slides: Investor update - Filings